Skip to main content
Equibles
GILD logo

GILD · Gilead Sciences, Inc. · Metrics

Track GILD — free

Use GILD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GILD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$156.04 -1.15 (-0.73%) At close · Oct 23
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$193.48B
Shares
1.24B
Volume · Oct 23 6.07M Avg daily vol (3M) 6.07M

GILD metrics

108 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$156.04
Market cap
$193.48B

Price action

20 metrics
Price change (1W)
-0.1%
Price change (30D)
+3.4%
Price change (3M)
+20.7%
Price change (6M)
+19.7%
Price change (YTD)
+27.1%
Price change (1Y)
+29.2%
Trailing year
Price change (5Y)
+132.1%
52-week high
$157.37
52-week low
$117.88
Change from 52-week high
-0.8%
Change from 52-week low
+32.4%
Annualized volatility
26.8%
Annualized volatility (3M)
25.7%
Beta
0.3
RSI (14D)
58.4
Price vs SMA 50
+4.8%
Price vs SMA 200
+12.4%
Avg volume (3M)
6.07M
Relative volume
1.0
Average dollar volume
$879.31M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
1.24B

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
7.1×
reciprocal yield 14.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
6.4×
reciprocal yield 15.7%
P / book
16.4
reciprocal yield 6.1%
FCF yield
6.7%
TTM · current market cap
Buyback yield
0.7%
P / FCF
14.9
reciprocal yield 6.7%
P / operating cash flow
14.3
reciprocal yield 7.0%
Earnings yield
-1.7%

Historical valuation

8 metrics
P / E historical average (3Y)
147.9×
reciprocal yield 0.7%
P / E historical average (5Y)
96.1×
reciprocal yield 1.0%
EV / revenue historical average (3Y)
5.8×
reciprocal yield 17.3%
EV / revenue historical average (5Y)
5.4×
reciprocal yield 18.4%
EV / EBIT historical average (3Y)
30.9×
reciprocal yield 3.2%
EV / EBIT historical average (5Y)
26.5×
reciprocal yield 3.8%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
2.1%
Trailing 12 months
Payout ratio
—
Shareholder yield
2.8%
Dividend / share (TTM)
$3.25
Dividend growth YoY
+3.5%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-15

Earnings calendar

2 metrics
Next earnings
2026-10-29
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
79.6%
Operating margin
-8.2%
Trailing 12 months
Net margin
-10.6%
Gross profit (TTM)
$24.24B
Operating profit (TTM)
−$2.50B
Net income (TTM)
−$3.24B
Trailing 12 months
Diluted EPS (TTM)
$-2.66
FCF margin
42.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$24.35
Gross profit per diluted share (TTM)
$19.38
Operating profit per diluted share (TTM)
$-2.06
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-2.66
Operating cash flow per diluted share (TTM)
$10.84
Free cash flow per diluted share (TTM)
$10.35
Capital expenditures per diluted share (TTM)
$0.49
R&D per diluted share (TTM)
$4.85
Stock compensation per diluted share (TTM)
$0.73
Book value per share
$18.29

Growth

11 metrics
Revenue growth YoY
+10.2%
Year over year
Net income growth YoY
-635.5%
Revenue (TTM)
$30.46B
Trailing 12 months
EPS growth YoY
-641.7%
Shares change YoY
-1.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.6%
Revenue CAGR (5Y)
+3.6%
EPS CAGR (3Y)
+23.0%
EPS CAGR (5Y)
+132.4%
FCF CAGR (3Y)
+4.3%
FCF CAGR (5Y)
+4.7%

Quality

14 metrics
Return on equity
-27.4%
Return on assets
-6.6%
Debt / equity
2.2
Current ratio
1.3
EBITDA (TTM)
—
Free cash flow (TTM)
$12.94B
Quick ratio
1.1
Interest coverage
-2.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$23.07B
Latest balance sheet
Cash & equivalents
$3.18B
Total assets
$49.36B
Total debt
$26.25B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$13.55B
Capital expenditures (TTM)
$609.00M
R&D (TTM)
$6.07B
SG&A (TTM)
$6.52B
Stock compensation (TTM)
$909.00M
R&D / revenue
19.9%
Stock compensation / revenue
3.0%

Ownership (13F)

9 metrics
13F filers
2,304
13F filer change QoQ
-35
Institutional ownership
90.9%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
13.1%
Private-fund adviser ownership
12.4%
Active holders' share change QoQ
+1.6%
Holder tenure
19.4
Price vs estimated holder cost
+7.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
19.7%

Short interest

3 metrics
Short interest
1.8%
Latest settlement · 3.4 days to cover
Days to cover
3.4d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$15.88M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 882095 CUSIP 375558103 13F (30d) 693 filings 673 filers Visit website Investor relations